Oramed Pharmaceuticals, Inc. (ORMP)
3.695
+0.04
(+1.23%)
USD |
NASDAQ |
Jun 10, 16:00
3.695
0.00 (0.00%)
After-Hours: 19:34
Oramed Pharmaceuticals EPS Diluted (TTM) : 2.584 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.584 |
| December 31, 2025 | 1.485 |
| September 30, 2025 | 1.003 |
| June 30, 2025 | -0.6084 |
| March 31, 2025 | -0.6988 |
| December 31, 2024 | -0.4764 |
| September 30, 2024 | 0.1091 |
| June 30, 2024 | 0.5091 |
| March 31, 2024 | 0.2579 |
| December 31, 2023 | 0.1361 |
| September 30, 2023 | -0.4106 |
| June 30, 2023 | -0.5115 |
| March 31, 2023 | -0.7533 |
| December 31, 2022 | -0.938 |
| September 30, 2022 | -0.9308 |
| June 30, 2022 | -0.9242 |
| March 31, 2022 | -0.8233 |
| August 31, 2021 | -0.7884 |
| May 31, 2021 | -0.7057 |
| February 28, 2021 | -0.6301 |
| November 30, 2020 | -0.6665 |
| August 31, 2020 | -0.5774 |
| May 31, 2020 | -0.5821 |
| February 29, 2020 | -0.717 |
| November 30, 2019 | -0.722 |
| Date | Value |
|---|---|
| August 31, 2019 | -0.823 |
| May 31, 2019 | -0.8718 |
| February 28, 2019 | -0.9385 |
| November 30, 2018 | -0.9265 |
| August 31, 2018 | -0.86 |
| May 31, 2018 | -0.88 |
| February 28, 2018 | -0.73 |
| November 30, 2017 | -0.77 |
| August 31, 2017 | -0.79 |
| May 31, 2017 | -0.95 |
| February 28, 2017 | -0.95 |
| November 30, 2016 | -0.85 |
| August 31, 2016 | -0.86 |
| May 31, 2016 | -0.69 |
| February 29, 2016 | -0.69 |
| November 30, 2015 | -0.70 |
| August 31, 2015 | -0.68 |
| May 31, 2015 | -0.65 |
| February 28, 2015 | -0.68 |
| November 30, 2014 | -0.65 |
| August 31, 2014 | -0.60 |
| May 31, 2014 | -0.55 |
| February 28, 2014 | -0.54 |
| November 30, 2013 | -0.59 |
| August 31, 2013 | -0.57 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Viatris, Inc. | -0.259 |
| Pfizer Inc. | 1.304 |
| SIGA Technologies, Inc. | 0.2817 |
| Bristol Myers Squibb Co. | 3.563 |
| ANI Pharmaceuticals, Inc. | 3.942 |